Evaluation of the Onset and Duration of Action of Bepotastine Besilate Ophthalmic Solution in Acute Allergic Conjunctivitis
Completed
Bausch & Lomb Incorporated
Phase 2/Phase 3
2007-02-01
The purpose of this study is to evaluate whether bepotastine besilate ophthalmic solution is
effective in the treatment of acute allergic conjunctivitis
The Evaluation of Bepreve on the Measurement of Wheal and Flare Response From Histamine Skin Prick Testing
Completed
North Texas Institute for Clinical Trials
Phase 4
2010-04-01
To evaluate the effect of BEPREVE compared to a REFRESH Tears Lubricant eye drop on the
measurement of the wheal and flare from histamine skin prick testing. This is an open label,
two-week, post-marketing study conducted on histamine responsive patients.
Use of BEPREVE (Bepotastine Besilate Ophthalmic Solution) 1.5% for Allergic Conjunctivitis and Contact Lenses
Unknown status
Bausch & Lomb Incorporated
Phase 4
2011-05-01
The purpose of this study is to assess if BEPREVE (bepotastine besilate ophthalmic solution)
1.5% will have an effect on contact lens wear in patients with contact lens intolerance due
to allergic conjunctivitis.
Use of BEPREVE (Bepotastine Besilate Ophthalmic Solution) 1.5% for Allergic Conjunctivitis and Contact Lenses
Unknown status
Hom, Milton M., OD, FAAO
Phase 4
2011-05-01
The purpose of this study is to assess if BEPREVE (bepotastine besilate ophthalmic solution)
1.5% will have an effect on contact lens wear in patients with contact lens intolerance due
to allergic conjunctivitis.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
